Best BCAA Grape
BPI Sports Best BCAA Grape is categorized as a protein supplement, specifically an 'Other Combinations' type, featuring a blend of branched-chain amino acids (BCAAs) and other compounds. Each serving provides 2.5 grams of Glycyl-Alanyl-Lysine-L-Leucine, 1.25 grams of Glycyl-Alanyl-Lysine-L-Isoleucine, and 1.25 grams of Glycyl-Alanyl-Lysine-L-Valine, alongside a 1-gram CLA Matrix and 250 mg of Agmatine. The product contains a total of 5 ingredients, with 100% label transparency regarding ingredient amounts. However, based on our analysis, it receives an N+ Score of 58, which corresponds to an 'F' grade, indicating that none of its key ingredients are present at clinically studied dosages. This product may appeal to individuals seeking a BCAA blend with additional ingredients, though research suggests higher BCAA dosages are often utilized for muscle support.
About This Product
Best BCAA Grape by BPI Sports is a protein supplement containing 5 active ingredients. It has earned an N+ Score of 58/100 (Grade F).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Glycyl-Alanyl-Lysine-L-Leucine | 2.500 Gram(s) | N/A |
| Glycyl-Alanyl-Lysine-L-Isoleucine | 1.250 Gram(s) | N/A |
| Glycyl-Alanyl-Lysine-L-Valine | 1.250 Gram(s) | N/A |
| CLA Matrix (Proprietary Blend) | 1.000 Gram(s) | N/A |
| Agmatine | 250.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.